I agree that this site is using cookies. You can find further informations here.
X
Krishnaswami, Sriram
73  results:
Search for persons X
?
1

Role of pharmacometrics and systems pharmacology in facilit..:

Jayachandran, Priya ; Desikan, Rajat ; Krishnaswami, Sriram.
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  11 - p. 1569-1572 , 2023
Link: https://doi.org/10.1002/..
 
?
2

CPT: Pharmacometrics & Systems Pharmacology – Inception, Ma..:

Rowland Yeo, Karen ; Hennig, Stefanie ; Krishnaswami, Sriram...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  7 - p. 649-657 , 2021
Link: https://doi.org/10.1002/..
 
?
3

Application of Physiologically Based Pharmacokinetic Modeli..:

Tse, Susanna ; Dowty, Martin E. ; Menon, Sujatha..
The Journal of Clinical Pharmacology.  60 (2020)  12 - p. 1617-1628 , 2020
Link: https://doi.org/10.1002/..
 
?
4

MID3: Mission Impossible or Model‐Informed Drug Discovery a..:

Krishnaswami, Sriram ; Austin, Daren ; Della Pasqua, Oscar...
Clinical Pharmacology & Therapeutics.  107 (2020)  4 - p. 762-772 , 2020
Link: https://doi.org/10.1002/..
 
?
5

Evaluation of the Short‐, Mid‐, and Long‐Term Effects of To..:

van Vollenhoven, Ronald ; Lee, Eun Bong ; Strengholt, Sander...
Arthritis & Rheumatology.  71 (2019)  5 - p. 685-695 , 2019
Link: https://doi.org/10.1002/..
 
?
6

Model‐Based Comparison of Dose‐Response Profiles of Tofacit..:

Suzuki, Misaki ; Shoji, Satoshi ; Miyoshi, So.
The Journal of Clinical Pharmacology.  60 (2019)  2 - p. 198-208 , 2019
Link: https://doi.org/10.1002/..
 
?
7

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinet..:

Miyoshi, So ; Krishnaswami, Sriram ; Toyoizumi, Shigeyuki..
Clinical Pharmacology in Drug Development.  9 (2019)  1 - p. 11-20 , 2019
Link: https://doi.org/10.1002/..
 
?
8

Toward Progress in Quantitative Translational Medicine: A C..:

Venkatakrishnan, Karthik ; Zheng, Songmao ; Musante, Cynthia J....
Clinical Pharmacology & Therapeutics.  107 (2019)  1 - p. 85-88 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Pharmacokinetic Characteristics of Tofacitinib in Adult Pat..:

Ma, Guangli ; Xie, Rujia ; Strober, Bruce...
Clinical Pharmacology in Drug Development.  7 (2018)  6 - p. 587-596 , 2018
Link: https://doi.org/10.1002/..
 
?
10

Brief Report: Remission Rates With Tofacitinib Treatment in..:

Smolen, Josef S. ; Aletaha, Daniel ; Gruben, David...
Arthritis & Rheumatology.  69 (2017)  4 - p. 728-734 , 2017
Link: https://doi.org/10.1002/..
 
?
11

Tofacitinib in Combination With Conventional Disease‐Modify..:

Strand, Vibeke ; Kremer, Joel M. ; Gruben, David...
Arthritis Care & Research.  69 (2017)  4 - p. 592-598 , 2017
Link: https://doi.org/10.1002/..
 
?
12

Pharmacokinetic and safety profile of tofacitinib in childr..:

for the Pediatric Rheumatology International Trials Organization (PRINTO) ; Ruperto, Nicolino ; Brunner, Hermine I....
Pediatric Rheumatology.  15 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
13

Predicting the probability of successful efficacy of a diss..:

Conrado, Daniela J. ; Krishnaswami, Sriram ; Shoji, Satoshi...
Journal of Pharmacokinetics and Pharmacodynamics.  43 (2016)  3 - p. 325-341 , 2016
Link: https://doi.org/10.1007/..
 
?
14

Evaluation of the Effect of Tofacitinib on the Pharmacokine..:

Menon, Sujatha ; Riese, Richard ; Wang, Ronnie...
Clinical Pharmacology in Drug Development.  5 (2016)  5 - p. 336-342 , 2016
Link: https://doi.org/10.1002/..
 
?
15

Use of a risk characterisation approach to contextualise th..:

Curtis, Jeffrey R. ; Zhang, Richard ; Krishnaswami, Sriram...
Clinical Rheumatology.  36 (2016)  3 - p. 683-688 , 2016
Link: https://doi.org/10.1007/..
 
1-15